This is evidenced by several clinical studies showing that serum OCN level was negatively correlated with systemic inflammatory markers, such as interleukin-6 (IL-6) and C-reactive protein (CRP), in patients with diabetes, obesity, or metabolic syndrome [30,31,32,33,34,35,36]. Here, IL6 is linked to metabolic syndrome.